Effectiveness and safety of follitropin delta in routine clinical practice in the Nordics and Switzerland (the NORSOS study): a prospective non-interventional study

BackgroundFollitropin delta is the first approved human recombinant follicle-stimulating hormone treatment administered through an algorithmic individualized dosing regimen based on body weight and anti-Müllerian hormone (AMH) levels. This study assesses the effectiveness and safety profile of folli...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Anja Pinborg, Negjyp Sopa, Erling Ekerhovd, Stavros I. Iliadis, June Kaspersen, Enrica Gravotta, Alexander Quaas
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2025-09-01
Serier:	Frontiers in Endocrinology
Fag:	follitropin delta in vitro fertilization assisted reproductive technology anti-Müllerian hormone pregnancy ovarian stimulation
Online adgang:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1613680/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!